ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Konica Minolta Inc (PK)

Konica Minolta Inc (PK) (KNCAY)

8.29
0.00
(0.00%)
Closed January 13 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
8.29
Bid
7.78
Ask
8.47
Volume
6
0.00 Day's Range 0.00
4.87 52 Week Range 9.302
Market Cap
Previous Close
8.29
Open
-
Last Trade
3
@
8.125
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,996
Shares Outstanding
246,944,063
Dividend Yield
0.76%
PE Ratio
0.21
Earnings Per Share (EPS)
18.31
Revenue
1.18T
Net Profit
4.52B

About Konica Minolta Inc (PK)

Sector
Photographic Equip & Supply
Industry
Photographic Equipment Retail
Headquarters
Chiyoda, Tokyo, Jpn
Founded
1984
Konica Minolta Inc (PK) is listed in the Photographic Equip & Supply sector of the OTCMarkets with ticker KNCAY. The last closing price for Konica Minolta (PK) was US$8.29. Over the last year, Konica Minolta (PK) shares have traded in a share price range of US$ 4.87 to US$ 9.302.

Konica Minolta (PK) currently has 246,944,063 shares outstanding. The market capitalization of Konica Minolta (PK) is US$2.05 billion. Konica Minolta (PK) has a price to earnings ratio (PE ratio) of 0.21.

KNCAY Latest News

Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil

Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil PR Newswire TOKYO, July 2, 2015 TOKYO, July 2, 2015 /PRNewswire/ -- Konica Minolta, Inc. (Konica...

Konica Minolta Launches New Blue Moon Lifecycle Solutions for AeroDR

Konica Minolta Launches New Blue Moon Lifecycle Solutions for AeroDR PR Newswire WAYNE, N.J., June 9, 2015 WAYNE, N.J., June 9, 2015 /PRNewswire/ -- Konica Minolta announced today new Blue Moon...

Konica Minolta Sensing Americas Adds Instrument Systems LumiCam 1300 Advanced to its Product Portfolio

Konica Minolta Sensing Americas Adds Instrument Systems LumiCam 1300 Advanced to its Product Portfolio PR Newswire RAMSEY, N.J., May 27, 2015 RAMSEY, N.J., May 27, 2015 /PRNewswire/ -- Konica...

Konica Minolta Sets Record Digital Radiography Sales

Konica Minolta Sets Record Digital Radiography Sales PR Newswire WAYNE, N.J., April 28, 2015 WAYNE, N.J., April 28, 2015 /PRNewswire/ -- Konica Minolta Medical Imaging Americas announced today it...

Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging

Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging PR Newswire WAYNE, N.J. and DETROIT, April 17, 2015 WAYNE, N.J. and DETROIT, April...

Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Mon...

Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation PR Newswire WAYNE, N.J., March 3, 2015...

Konica Minolta Develops FD-9, World's Fastest(*1) Auto-Scanning Spectrophotometer, Bringing Improved Accuracy in Color Manage...

Konica Minolta Develops FD-9, World's Fastest(*1) Auto-Scanning Spectrophotometer, Bringing Improved Accuracy in Color Management to Users in the Printing Industry -- To Be Launched Worldwide in...

USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT

USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT PR Newswire WAYNE, N.J., Dec. 19, 2014 WAYNE, N.J., Dec. 19, 2014 /PRNewswire/ -- In the Friday, December 19...

Konica Minolta Launches SONIMAGE HS1 High-end, Hand-held Ultrasound System at RSNA 2014

Konica Minolta Launches SONIMAGE HS1 High-end, Hand-held Ultrasound System at RSNA 2014 PR Newswire WAYNE, N.J., Nov. 30, 2014 WAYNE, N.J., Nov. 30, 2014 /PRNewswire/ -- Today at the annual...

New ImagePilot Aero Delivers Performance, Exam Flexibility and Economic Value for Orthopedic Clinics

New ImagePilot Aero Delivers Performance, Exam Flexibility and Economic Value for Orthopedic Clinics PR Newswire WAYNE, N.J., Nov. 19, 2014 WAYNE, N.J., Nov. 19, 2014 /PRNewswire/ -- Konica...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1008.298.298.291008.29DR
4-0.87-9.497816593899.169.168.292818.58845083DR
121.8929.531256.49.3026.429967.9621052DR
262.53544.04865334495.7559.3024.8720097.43321296DR
522.4642.19554030875.839.3024.8729236.79634054DR
156-0.925-10.03798155189.2159.38524.8731707.14106662DR
260-5.02-37.716003005313.3113.314.83529517.89362171DR

KNCAY - Frequently Asked Questions (FAQ)

What is the current Konica Minolta (PK) share price?
The current share price of Konica Minolta (PK) is US$ 8.29
How many Konica Minolta (PK) shares are in issue?
Konica Minolta (PK) has 246,944,063 shares in issue
What is the market cap of Konica Minolta (PK)?
The market capitalisation of Konica Minolta (PK) is USD 2.05B
What is the 1 year trading range for Konica Minolta (PK) share price?
Konica Minolta (PK) has traded in the range of US$ 4.87 to US$ 9.302 during the past year
What is the PE ratio of Konica Minolta (PK)?
The price to earnings ratio of Konica Minolta (PK) is 0.21
What is the cash to sales ratio of Konica Minolta (PK)?
The cash to sales ratio of Konica Minolta (PK) is 0
What is the reporting currency for Konica Minolta (PK)?
Konica Minolta (PK) reports financial results in JPY
What is the latest annual turnover for Konica Minolta (PK)?
The latest annual turnover of Konica Minolta (PK) is JPY 1.18T
What is the latest annual profit for Konica Minolta (PK)?
The latest annual profit of Konica Minolta (PK) is JPY 4.52B
What is the registered address of Konica Minolta (PK)?
The registered address for Konica Minolta (PK) is 2-7-2 MARUNOUCHI, CHIYODA-KU, CHIYODA, TOKYO, 100-7015
What is the Konica Minolta (PK) website address?
The website address for Konica Minolta (PK) is www.konicaminolta.com
Which industry sector does Konica Minolta (PK) operate in?
Konica Minolta (PK) operates in the PHOTOGRAPHIC EQUIPMENT RETAIL sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRGPCalissio Resources Group Inc (CE)
US$ 0.0004
(39,900.00%)
20k
NEOMNeoMedia Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
534.97k
SMMESmartMetric Inc (PK)
US$ 0.0001
(9,900.00%)
1.25M
RRGIReality Racing Inc (CE)
US$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
US$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
US$ 0.00025
(-16.67%)
129.87M

Discussion

View Full Feed
IVRT IVRT 12 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 12 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 13 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 14 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 21 minutes ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 24 minutes ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 30 minutes ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 30 minutes ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 34 minutes ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 35 minutes ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 41 minutes ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 42 minutes ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 44 minutes ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 46 minutes ago
He would smother any question with words.
Shawonsarker84 Shawonsarker84 47 minutes ago
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 49 minutes ago
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 53 minutes ago
Oh noooooo.....
FNMA
StockItOut StockItOut 54 minutes ago
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 1 hour ago
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 1 hour ago
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL
Louinjaxxx Louinjaxxx 1 hour ago
The reversal on Friday just reflects the entire market downturn on Friday.
AXXA
Steady_T Steady_T 1 hour ago
That sounds pretty optimistic to me. I'd think that the RA would like to see some data on other cancers before such a broad scope label.
NWBO
boi568 boi568 1 hour ago
I think he edited the question he asked to make it look neutral.
AVXL
Louinjaxxx Louinjaxxx 1 hour ago
So the extra 5 to 6 million shares will help you pay the taxes on you gain?  That makes sense.
AXXA

Your Recent History

Delayed Upgrade Clock